Barrington将阿尼卡医疗(Anika Therapeutics)的评级从“与大盘持平”上调至“跑赢大盘”,并给出目标价24美元。该行认为,该公司目前的风险回报水平“非常有利于投资”。#医疗# $阿尼哥医疗(ANIK)$查看全文
usbiostock2018-06-20 09:17
$阿尼哥医疗(ANIK)$ CINGAL® 16-02治疗膝盖骨关节炎临床3期试验未能满足主要终点。虽然在治疗后各个时间点,CINGAL® 16-02均能降低疼痛,但在主要终点(第26周)上却没有统计学意义。查看全文
usbiostock2018-06-20 09:17
$阿尼哥医疗(ANIK)$ CINGAL® 16-02治疗膝盖骨关节炎临床3期试验未能满足主要终点。虽然在治疗后各个时间点,CINGAL® 16-02均能降低疼痛,但在主要终点(第26周)上却没有统计学意义。查看全文
BlackPuma2014-10-30 07:44
10月中旬,福布斯依据最近12个月和过去五年的股本回报率、销售额增长和盈利增长,给出了销售额在10亿美元以下的美国小型上市公司TOP100榜单。相对于市值数十亿美元的大公司,小市值股对更多的投资者则代表着更为巨大的机会和增长潜力。
今年是福布斯第36届评选该榜单,入选TOP100企业遍及宇航...查看全文
$阿尼哥医疗(ANIK)$ DEF 14A - Other definitive proxy statements Filed: 2019-04-25 AccNo: 0001171843-19-002640 Size: 1 MB 网页链接
$阿尼哥医疗(ANIK)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2019-04-25 AccNo: 0001171843-19-002642 Size: 978 KB 网页链接
$阿尼哥医疗(ANIK)$ 美东时间 2019-05-02 盘后 披露财报,预期EPS 0.21 网页链接
$阿尼哥医疗(ANIK)$ 8-K - Current report Filed: 2019-04-12 AccNo: 0001171843-19-002383 Size: 236 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial S...
$阿尼哥医疗(ANIK)$ 8-K - Current report Filed: 2019-03-26 AccNo: 0001171843-19-001983 Size: 16 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$阿尼哥医疗(ANIK)$ 内部交易: 2019-02-26,Director,LAND RAYMOND J ,卖出,4000普通股, $33.06
$阿尼哥医疗(ANIK)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-02-27 AccNo: 0001171843-19-001243 Size: 6 MB 网页链接
$阿尼哥医疗(ANIK)$ 8-K - Current report Filed: 2019-02-21 AccNo: 0001157523-19-000413 Size: 155 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$阿尼哥医疗(ANIK)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-12 AccNo: 0000902219-19-000124 Size: 33 KB 网页链接
$阿尼哥医疗(ANIK)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-12 AccNo: 0001567619-19-003279 Size: 66 KB 网页链接